Recent publications
Article
Nicolson, PLR, Belete, M, Hawes, R, Fowler, N & Toh, C-H 2024, 'Alternative routes into clinical research: a guide for early career doctors', BMJ, vol. 385, e076414. https://doi.org/10.1136/bmj-2023-076414
Gardner, J, Abrams, ST, Toh, C-H, Parker, AL, Lovatt, C, Nicolson, PLR, Watson, SP, Grice, S, Hering, L, Pirmohamed, M & Naisbitt, DJ 2024, 'Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines', NPJ vaccines, vol. 9, no. 1, 99. https://doi.org/10.1038/s41541-024-00895-z
Cooper, N, Scully, M, Percy, C, Nicolson, P, Lowe, G, Bagot, C, Thachil, J, Grech, H, Noakes, T, Hill, Q, Bradbury, C, Talks, K, Dutt, T, Evans, G, Pavord, S, Wexler, SK, Charania, A, Collington, SJ, Ervin, A, Ramscar, N & Provan, D 2024, 'Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study', British Journal of Haematology. https://doi.org/10.1111/bjh.19345
Smith, C, Campos, J, Brown, H, Ivanova, V-S, Harbi, M, Garcia Quintanilla, L, Jossi, S, Perez-Toledo, M, Rookes, K, Brill, A, Theodore, L, Owens, T, LaStant, J, Foulke, MC, Mukai, S, Francesco, M, Storek, M, Hicks, A, Langrish, C, Nunn, PA, Cunningham, A, Chauhan, A, Thomas, MR, Watson, S & Nicolson, P 2024, 'Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice', Blood Advances. https://doi.org/10.1182/bloodadvances.2024012713
Sherratt-Mayhew, S & Nicolson, P 2024, 'Use of IV Immunoglobulin to Treat Steroid Resistant, Immune Checkpoint Inhibitor induced Pure Red Cell Aplasia: A Case Report', EJHaem. https://doi.org/10.1002/jha2.937
Alenazy, F, Harbi, M, Kavanagh, D, Price, J, Brady, P, Hargreaves, O, Harrison, P, Slater, A, Tiwari, A, Nicolson, P, Connolly, D, Kirchhof, P, Kalia, N, Jandrot-Perrus, M, Mangin, PH, Watson, S & Thomas, MR 2023, 'Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy JTH', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 11, pp. 3236-3251. https://doi.org/10.1016/j.jtha.2023.07.018
Abrams, S, Du, M, Shaw, RJ, Johnson, C, McGiuiness, D, Schofield, J, Yong, J, Turtle, L, Nicolson, P, Moxon, C, Wang, G & Toh, C-H 2023, 'Damage-associated cellular markers in the clinical and pathogenic profile of Vaccine-induced Immune Thrombotic Thrombocytopenia', Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.12.008
Whyte, CS, Morrow, GB, Gauer, JS, Montague, S & Nicolson, P 2023, 'Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting', Front Cardiovasc Med, vol. 10, 1225243. https://doi.org/10.3389/fcvm.2023.1225243
Buka, R, Montague, S, Moran, LA, Martin, E, Slater, A, Watson, S & Nicolson, P 2023, 'PF4 activates the c-Mpl-Jak2 pathway in platelets', Blood. https://doi.org/10.1182/blood.2023020872
Kemble, S, Dalby, A, Lowe, G, Nicolson, P, Watson, S, Senis, Y, Thomas, S & Harrison, P 2022, 'Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry', Blood Advances, vol. 6, no. 9, pp. 2932–2946. https://doi.org/10.1182/bloodadvances.2021006073
Montague, S, Smith, C, Lodwick, CS, Stoneley, C, Roberts, M, Lowe, G, Lester, W, Watson, S & Nicolson, P 2022, 'Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: persistent positivity through 7 months', Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 3, e12707. https://doi.org/10.1002/rth2.12707
Harbi, M, Smith, C, Alenazy, F, Nicolson, P, Tiwari, A, Watson, S & Thomas, MR 2022, 'Antithrombotic effects of fostamatinib in combination with conventional antiplatelet drugs', International Journal of Molecular Sciences, vol. 23, no. 13, 6982. https://doi.org/10.3390/ijms23136982
Comment/debate
Buka, R, Nicolson, P & Sutton, D 2024, 'Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate', Journal of Thrombosis and Thrombolysis, vol. 57, pp. 739-741. https://doi.org/10.1007/s11239-024-02948-5
Letter
Glancy, P, Sutton, D, Gomez, K, Nicolson, P & Buka, R 2023, 'How will UK hospitals use andexanet alfa? A review of local protocols', EJHaem, vol. 4, no. 1, pp. 298–300. https://doi.org/10.1002/jha2.648
Nicolson, P 2022, 'A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR “Flash-Mob” retrospective study incorporating 961 patients', British Journal of Haematology, vol. 196, no. 2, pp. 433-437. https://doi.org/10.1111/bjh.17692
View all publications in research portal